Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
5.045
+0.18
(+3.81%)
USD |
NASDAQ |
Oct 26, 16:00
5.14
+0.10
(+1.88%)
After-Hours: 20:00
Shuttle Pharmaceuticals Holdings EPS Diluted (Quarterly) : -3.098 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.098 |
| March 31, 2026 | -4.278 |
| December 31, 2025 | -12.92 |
| September 30, 2025 | -10.51 |
| June 30, 2025 | -32.92 |
| March 31, 2025 | -0.3038 |
| December 31, 2024 | -98.03 |
| September 30, 2024 | -1.587 |
| June 30, 2024 | -0.965 |
| March 31, 2024 | -0.8339 |
| December 31, 2023 | -0.8167 |
| Date | Value |
|---|---|
| September 30, 2023 | -0.911 |
| June 30, 2023 | -306.76 |
| March 31, 2023 | -0.5721 |
| December 31, 2022 | -0.4416 |
| September 30, 2022 | -0.5994 |
| June 30, 2022 | -0.3669 |
| March 31, 2022 | -0.4166 |
| December 31, 2021 | -0.2854 |
| September 30, 2021 | -0.143 |
| June 30, 2021 | -0.2194 |
| March 31, 2021 | -0.0914 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.146M |
| Total Expenses (Quarterly) | 3.146M |
| Enterprise Value | 5.156M |
| Earnings Yield | -610.6% |
| Normalized Earnings Yield | -632.99 |